跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BARNIDIPINO SWANPOND INVESTMENTS 20 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BARNIDIPINO SWANPOND INVESTMENTS 20 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG
Approved
STANDARD
BARNIDIPINO SWANPOND INVESTMENTS 20 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG
Swan Pond Investments Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 5, 2023
Approval ID
54c8f77e4e18d295
Company
Swan Pond Investments Limited
Type
Standard
Approval Details
Approval Id
54c8f77e4e18d295
Drug Cima Aemps Name
BARNIDIPINO SWANPOND INVESTMENTS 20 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG
Register Number
88765
Holder Company Name
Swan Pond Investments Limited
Marketing Company Name
Swan Pond Investments Limited
Authorization Date
2023-04-05
Dosage Form
CÁPSULA DURA DE LIBERACIÓN MODIFICADA
Dose
20 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Swan Pond Investments Limited
Active Ingredients
BARNIDIPINO HIDROCLORURO
20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 5, 2023
Approval ID
54c8f77e4e18d295
Type
Standard
Back to CIMA-AEMPS Approvals